2015
DOI: 10.3109/03639045.2015.1054396
|View full text |Cite
|
Sign up to set email alerts
|

P-glycoprotein inhibition of drug resistant cell lines by nanoparticles

Abstract: Several pharmaceutical excipients are known for their ability to interact with cell membrane lipids and reverse the phenomenon of multidrug resistance (MDR) in cancer. Interestingly, many excipients act as stabilizers and are key ingredients in a variety of nano-formulations. In this study, representatives of ionic and non-ionic excipients were used as surface active agents in nanoparticle (NP) formulations to utilize their MDR reversing potential. In-vitro assays were performed to elucidate particle-cell inte… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
7
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(9 citation statements)
references
References 27 publications
2
7
0
Order By: Relevance
“…The low hemolytic property of Solutol HS 15 suggests that it has a low toxicity and irritation. Solutol HS 15 has been reported to modulate the cytotoxicity and the accumulation of anticancer drugs by P-gp inhibition (Coon et al, 1991;Singh & Lamprecht, 2015). It is suspected that this inhibition is mediated by changing the plasma membrane fluidity of multidrug resistance (MDR) cells.…”
Section: Introductionmentioning
confidence: 99%
“…The low hemolytic property of Solutol HS 15 suggests that it has a low toxicity and irritation. Solutol HS 15 has been reported to modulate the cytotoxicity and the accumulation of anticancer drugs by P-gp inhibition (Coon et al, 1991;Singh & Lamprecht, 2015). It is suspected that this inhibition is mediated by changing the plasma membrane fluidity of multidrug resistance (MDR) cells.…”
Section: Introductionmentioning
confidence: 99%
“…19 Solutol HS 15 has been reported to modulate the cytotoxicity and the accumulation of anticancer drugs by P-gp inhibition. 20 PEG seems to be a selective and potent modulator of organic anion transporting polypeptides 1A2 with half-maximal inhibitory concentration (IC 50 ) values of 0.05% (taurocholate) and 0.14% (estrone-3-sulfate). It has been shown to interact with cytochrome P450-dependent drug metabolism as well as efflux transporters such as P-glycoprotein (ABCB1) and MDR-associated protein 2 (ABCC2).…”
Section: Introductionmentioning
confidence: 99%
“…Residual stabilizer issue is frequently underestimated and misconstrued . In the former case, it has been reported that the researchers claimed to use the “uncoated” nanoparticles.…”
Section: Discussionmentioning
confidence: 99%